Published in
Elsevier, European Neuropsychopharmacology, (21), p. S506-S507
DOI: 10.1016/s0924-977x(11)70823-9
Links
Tools
P.3.d.001 Development of novel antipsychotic drugs based on olanzapine that display reduced weight gain and metabolic side effects
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 